Pharmaceutical

Celltrion USA seeks FDA approval for CT-P47 biosimilar

Celltrion USA has filed a biologics licence application (BLA) with the US FDA for its biosimilar candidate CT-P47.

Jan 29, 2024 - 18:00
Celltrion USA seeks FDA approval for CT-P47 biosimilar
Celltrion USA has filed a biologics licence application (BLA) with the US FDA for its biosimilar candidate CT-P47.
Read the original article

Tags:

Previous Article

FDA grants priority review for Daiichi Sankyo-AstraZeneca’s Enhertu

Next Article

Bristol Myers Squibb’s Abecma recommended for EU approval

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: The clock is ticking, and Cytokinetics is running out of December

STAT+: The clock is ticking, and Cytokinetics is runnin...

Dec 25, 2023

Generate:Biomedicines and Novartis link on protein therapeutics development

Generate:Biomedicines and Novartis link on protein ther...

Sep 26, 2024

Opinion: Fear-based messaging doesn’t stop drug use. But it does make things worse

Opinion: Fear-based messaging doesn’t stop drug use. Bu...

May 11, 2023